New public consultations for IMP GMP and clinical trials opened

The European Commission has opened four new public consultations relating to good manufacturing practices (GMP) and clinical trials for human medicinal products. The consultations, which opened on the 28th August and close on the 24th November 2015, will seek the views of stakeholders with regards to the principles, guidelines and inspection arrangements for investigational medicinal products, medicinal products for human use and clinical trials. If you would like more information on how the proposed changes to the GMP and clinical trials guidance may impact your product development, please contact us on enquiries@wainwrightassociates.co.uk or call +44 (0)1628 530554.

For more information on New public consultations for IMP GMP and clinical trials opened talk to PharmaLex UK Services Limited